Bernie Sanders Wants to Meet Novo CEO Next Week on Ozempic Price
- Sanders slams $1,000 monthly price for Ozempic as outrageous
- Ozempic can be made for under $5 a month, recent study found
This article is for subscribers only.
Senator Bernie Sanders wants to meet next week with Novo Nordisk A/S’s top executive about lowering the price of its blockbuster drug Ozempic, fueling controversy over the costs of GLP-1 drugs for diabetes and obesity.
The Vermont independent said he’s considering hearings on the cost of GLP-1 drugs like Ozempic, but first wants to personally discuss their prices with Novo Chief Executive Officer Lars Fruergaard Jørgensen.